top of page

Metabolomics Improves 10-Year Cardiovascular Risk Prediction in Type 2 Diabetes

Feb 24
0 min read
Graphical abstract showing UK Biobank/ESTHER cohorts, sex-specific metabolite selection, and C-index gains from adding NMR markers to SCORE2-Diabetes.

 
 
bottom of page